SCHEMBL13071971

SCHEMBL13071971

CC(=N)c1ccc(CC(F)(F)F)cc1

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ESR1 P03372 2/20 0.34
▸ KMT2A Q03164 1/20 0.34
▸ THRA P10827 1/20 0.34
▸ THRB P10828 1/20 0.34
▸ EPHX2 P34913 1/20 0.34
▸ NR1H4 Q96RI1 1/20 0.34
▸ ALDH1A1 P00352 2/20 0.33
▸ F10 P00742 1/20 0.33
▸ LOXL2 Q9Y4K0 1/20 0.33
▸ PRSS1 P07477 1/20 0.33
▸ PRSS2 P07478 1/20 0.33
▸ PRSS3 P35030 1/20 0.33
▸ MAOB P27338 1/20 0.33
▸ IDO1 P14902 2/20 0.32
▸ ESR2 Q92731 1/20 0.31
▸ ABL1 P00519 1/20 0.31
▸ LMNA P02545 2/20 0.31
▸ POLB P06746 1/20 0.31
▸ RXRA P19793 1/20 0.30
▸ RXRB P28702 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22868057 0.83 PRSS1 (0.35) ESR1THRATHRBEPHX2NR1H4
SCHEMBL9889057 0.81 ESR1 (0.56) ESR1KMT2ATHRATHRBEPHX2
SCHEMBL18103219 0.79 KMT2A (0.59) KMT2ATHRATHRBEPHX2NR1H4
SCHEMBL22102029 0.78 NOS3 (0.32) EPHX2NR1H4IDO1
SCHEMBL7670360 0.76 ESR1 (0.38) ESR1ALDH1A1LOXL2MAOBIDO1
SCHEMBL11583858 0.75 KMT2A (0.58) ESR1KMT2AALDH1A1F10LOXL2
SCHEMBL22868058 0.74 SRD5A2 (0.50) ESR1THRATHRBEPHX2NR1H4
SCHEMBL18644564 0.74 NOS3 (0.39) ESR1KMT2AALDH1A1PRSS1PRSS2
SCHEMBL21020735 0.73 THRA (0.34) ESR1THRATHRBEPHX2NR1H4
SCHEMBL10308978 0.73 ALDH1A1 (0.54) KMT2AALDH1A1PRSS1IDO1RXRA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100297035-A1 Thiazole Amides, Imidazole Amides and Related Analogues LIGAND PHARMACEUTICALS, INC. (US) 2010-11-25 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100297035-A1 Thiazole Amides, Imidazole Amides and Related Analogues HRH3, HRH4, HRH2 ESR1 2352/4885KMT2A 890/4885THRA 38/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback